<p>PP: Primary Progressive; RR: Recurring Remitting; SP: Secondary Progressive; SEM: Standard error of the mean.</p
<p><i>Abbreviations</i>: RR = Relapsing-remitting, SP = Secondary progressive, PP = Primary progress...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
<p>Overall lifetime cancer prevalence and specific subtypes of cancer prevalence in patients with MS...
Findings regarding cancer risk in people with multiple sclerosis have been inconsistent and few stud...
<p><sup>*</sup>P-values (crude) were calculated from analysis of variance (ANOVA), α = 0.05.</p><p><...
<p>RRMS: recurrent-remittent MS; SPMS: secondary-progressive MS; CIS: clinically isolated syndrome.<...
<p>Data are reported as mean ±SE.</p><p>Abbreviations used: MS, multiple sclerosis; m, male; f, fema...
Approximately 85%-90 % of patients with multiple sclerosis (MS) will begin their disease with a cour...
a<p>Age (in years) refers to age at sampling time point.</p>b<p>Disease duration (in years) refers t...
<p>Incidence rate, Hazard ratios (HR) and 95% confidence intervals (CI) for association between MS a...
<p>*Relapsing–remitting (RR) and primary progressive (PP) MS.</p><p>**Clinical activity = presence...
Background: It is unclear if all patients with relapsing remitting multiple sclerosis (RRMS) ultimat...
<p>PP = progressive-relapsing multiple sclerosis; RR = relapsing-remitting multiple sclerosis; SP = ...
<p>M, male; F, female; yrs, years; R, relapsing; P, progressive; MSSS, Multiple.</p><p>Sclerosis Sev...
<p><i>Abbreviations</i>: RR = Relapsing-remitting, SP = Secondary progressive, PP = Primary progress...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
<p>Overall lifetime cancer prevalence and specific subtypes of cancer prevalence in patients with MS...
Findings regarding cancer risk in people with multiple sclerosis have been inconsistent and few stud...
<p><sup>*</sup>P-values (crude) were calculated from analysis of variance (ANOVA), α = 0.05.</p><p><...
<p>RRMS: recurrent-remittent MS; SPMS: secondary-progressive MS; CIS: clinically isolated syndrome.<...
<p>Data are reported as mean ±SE.</p><p>Abbreviations used: MS, multiple sclerosis; m, male; f, fema...
Approximately 85%-90 % of patients with multiple sclerosis (MS) will begin their disease with a cour...
a<p>Age (in years) refers to age at sampling time point.</p>b<p>Disease duration (in years) refers t...
<p>Incidence rate, Hazard ratios (HR) and 95% confidence intervals (CI) for association between MS a...
<p>*Relapsing–remitting (RR) and primary progressive (PP) MS.</p><p>**Clinical activity = presence...
Background: It is unclear if all patients with relapsing remitting multiple sclerosis (RRMS) ultimat...
<p>PP = progressive-relapsing multiple sclerosis; RR = relapsing-remitting multiple sclerosis; SP = ...
<p>M, male; F, female; yrs, years; R, relapsing; P, progressive; MSSS, Multiple.</p><p>Sclerosis Sev...
<p><i>Abbreviations</i>: RR = Relapsing-remitting, SP = Secondary progressive, PP = Primary progress...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
DOI
Add to ORKG